Free tool
FAERS Monitor: Travasol 10% In Plastic Container
Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018931 or its brand name (Travasol 10% In Plastic Container, Amino Acids). Reports on generic versions are filed under their own applications.
Reports
66
Serious
42
64% of reports
Hospitalization
13
Death reported
9
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- no adverse event9
- vomiting7
- death6
- incorrect dose administered6
- dyspnoea5
- pain5
- fatigue4
- nausea4
- transfusion4
- blood fibrinogen increased3
- blood glucose decreased3
- drug dispensing error3
- fall3
- gait disturbance3
- international normalised ratio increased3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 9 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,093 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood fibrinogen increasedSignal | 3 | 1217.6 | 402.1 | 2,522 |
| transfusionSignal | 4 | 121.7 | 47.1 | 366 |
| drug dispensing errorSignal | 3 | 62.6 | 20.7 | 126 |
| international normalised ratio increasedSignal | 3 | 33.5 | 11.1 | 65 |
| blood glucose decreasedSignal | 3 | 19.9 | 6.6 | 37 |
| no adverse eventSignal | 9 | 15.8 | 8.6 | 112 |
| incorrect dose administeredSignal | 6 | 8.4 | 3.9 | 32 |
| gait disturbanceSignal | 3 | 5.0 | 1.7 | 6 |
| vomitingSignal | 7 | 4.7 | 2.4 | 18 |
| fall | 3 | 2.9 | 1.0 | 2 |
| dyspnoeaSignal | 5 | 2.8 | 1.2 | 4 |
| pain | 5 | 2.6 | 1.1 | 4 |
| death | 6 | 2.2 | 1.0 | 3 |
| fatigue | 4 | 1.6 | 0.6 | 0 |
| nausea | 4 | 1.6 | 0.6 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.